Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
The Journal of Clinical Investigation
|
March 21, 1998
IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach
K Asadullah, W Sterry, K Stephanek, et al.
Archives of Dermatology
|
March 3, 1999
Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial
K Asadullah, W D Döcke, M Ebeling, et al.
Advances in Experimental Medicine and Biology
|
February 23, 1999
A phase I trial with a hybrid cell vaccine in patients with metastatic melanoma
U Trefzer, G Weingart, Y Chen, et al.
Immunobiology
|
June 2, 2000
Clonal evolution in a primary cutaneous follicle center B cell lymphoma revealed by single cell analysis in sequential biopsies
S Golembowski, S Gellrich, M von Zimmermann, et al.
International Journal of Cancer
|
March 4, 2000
Hybrid cell vaccination for cancer immune therapy: first clinical trial with metastatic melanoma
U Trefzer, G Weingart, Y Chen, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
April 11, 2003
[Red-brown infiltrates on the trunk of a 70-year-old-man with "elevated sedimentation rate"]
R A Herbst, T Brinkmeier, H Audring, et al.
The Journal of Investigative Dermatology
|
March 12, 2002
Primary cutaneous follicle center cell lymphomas and large B cell lymphomas of the leg descend from germinal center cells. A single cell polymerase chain reaction analysis
S Gellrich, S Rutz, S Golembowski, et al.
The Journal of Investigative Dermatology
|
May 12, 2001
Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findings
K Asadullah, M Friedrich, S Hanneken, et al.
Annals of the Rheumatic Diseases
|
September 10, 2005
New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists
S Kary, M Worm, H Audring, et al.
The British Journal of Dermatology
|
February 16, 2007
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists
H-H Lee, I-H Song, M Friedrich, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
The Journal of Clinical Investigation
|
March 21, 1998
IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach
K Asadullah, W Sterry, K Stephanek, et al.
Archives of Dermatology
|
March 3, 1999
Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial
K Asadullah, W D Döcke, M Ebeling, et al.
Advances in Experimental Medicine and Biology
|
February 23, 1999
A phase I trial with a hybrid cell vaccine in patients with metastatic melanoma
U Trefzer, G Weingart, Y Chen, et al.
Immunobiology
|
June 2, 2000
Clonal evolution in a primary cutaneous follicle center B cell lymphoma revealed by single cell analysis in sequential biopsies
S Golembowski, S Gellrich, M von Zimmermann, et al.
International Journal of Cancer
|
March 4, 2000
Hybrid cell vaccination for cancer immune therapy: first clinical trial with metastatic melanoma
U Trefzer, G Weingart, Y Chen, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
April 11, 2003
[Red-brown infiltrates on the trunk of a 70-year-old-man with "elevated sedimentation rate"]
R A Herbst, T Brinkmeier, H Audring, et al.
The Journal of Investigative Dermatology
|
March 12, 2002
Primary cutaneous follicle center cell lymphomas and large B cell lymphomas of the leg descend from germinal center cells. A single cell polymerase chain reaction analysis
S Gellrich, S Rutz, S Golembowski, et al.
The Journal of Investigative Dermatology
|
May 12, 2001
Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findings
K Asadullah, M Friedrich, S Hanneken, et al.
Annals of the Rheumatic Diseases
|
September 10, 2005
New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists
S Kary, M Worm, H Audring, et al.
The British Journal of Dermatology
|
February 16, 2007
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists
H-H Lee, I-H Song, M Friedrich, et al.
Page
of 8